Literature DB >> 5350969

The antigenic subunits of influenza viruses. I. The homologous antibody response.

R G Webster, F M Davenport.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5350969

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.

Authors:  D W Barry; E Staton; R E Mayner
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

2.  Influence of histones on the antibody response in guinea pigs to vaccination with A-Aichi-2-68 (H3 N2) influenza virus.

Authors:  J Drescher; G Gillissen
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

3.  Antigenic relationship between the surface antigens of avian and equine influenze viruses.

Authors:  R Rott; H Becht
Journal:  Med Microbiol Immunol       Date:  1975-09-19       Impact factor: 3.402

4.  Description of a technique for the determination of the concentration and quality of rubella virus antibody molecules and experience with testing sera from humans with recent and past rubella infection.

Authors:  G Hoppe; J Drescher
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

Review 5.  Challenges of Making Effective Influenza Vaccines.

Authors:  Sigrid Gouma; Elizabeth M Anderson; Scott E Hensley
Journal:  Annu Rev Virol       Date:  2020-05-11       Impact factor: 10.431

Review 6.  Vaccination against virus diseases.

Authors:  K R Schell
Journal:  Soz Praventivmed       Date:  1979-10

7.  A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus.

Authors:  Gregory M Frank; Davide Angeletti; William L Ince; James S Gibbs; Surender Khurana; Adam K Wheatley; Edward E Max; Adrian B McDermott; Hana Golding; James Stevens; Jack R Bennink; Jonathan W Yewdell
Journal:  MBio       Date:  2015-08-04       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.